vanilmandelic acid has been researched along with Thalassemia in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thirawarapan, SS | 1 |
| Snongchart, N | 1 |
| Fucharoen, S | 1 |
| Tanphaichitr, VS | 1 |
| Dhorranintra, B | 1 |
1 other study available for vanilmandelic acid and Thalassemia
| Article | Year |
|---|---|
Study of mechanisms of post-transfusion hypertension in thalassaemic patients.
Topics: Adolescent; Adult; Blood Viscosity; Child; Child, Preschool; Female; Furosemide; Hematocrit; Humans; | 1989 |